Application 212238
- Type
- ANDA
- Sponsor
- RISING
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | TRIENTINE HYDROCHLORIDE | TRIENTINE HYDROCHLORIDE | CAPSULE;ORAL | 250MG | No | No |
| 002 | TRIENTINE HYDROCHLORIDE | TRIENTINE HYDROCHLORIDE | CAPSULE;ORAL | 500MG | No | Yes |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 16571-810 | Trientine Hydrochloride | Trientine Hydrochloride | Rising Pharma Holdings, Inc. | ANDA | Current |
| 16571-810 | Trientine Hydrochloride | Trientine Hydrochloride | Rising Pharma Holdings, Inc. | ANDA | Current |
| 16571-812 | Trientine Hydrochloride | Trientine Hydrochloride | Rising Pharma Holdings, Inc. | ANDA | Current |
| 64980-450 | Trientine hydrochloride | Trientine hydrochloride | Rising Pharmaceuticals, Inc. | ANDA | Current |
| 64980-450 | Trientine hydrochloride | Trientine hydrochloride | Rising Pharmaceuticals, Inc. | ANDA | Current |